RIL
SLDB icon

Rothschild Investment LLC’s Solid Biosciences SLDB Stock Holding History

Rothschild Investment LLC’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5K Buy
150
+75
+100% +$569 ﹤0.01% 2879
2026
Q1 		$540 Hold
75
– – ﹤0.01% 3105
2025
Q4 		$423 Hold
75
– – ﹤0.01% 2961
2025
Q3 		$463 Hold
75
– – ﹤0.01% 2846
2025
Q2 		$365 Buy
+75
New +$265 ﹤0.01% 2828

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rothschild Investment LLC's SLDB Position: Q2 2026 in Review

Rothschild Investment LLC increased its Solid Biosciences (SLDB) stake by 100% in Q2 2026, buying an estimated $569 and bringing the position to 150 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2879.

Rothschild Investment LLC first reported a position in SLDB in Q2 2025 and has held it in 5 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Rothschild Investment LLC held 150 shares of Solid Biosciences worth $1.5K as of Q2 2026.
  • Rothschild Investment LLC bought 75 Solid Biosciences shares in Q2 2026, an estimated $569.
  • Solid Biosciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2879 holding.
  • Rothschild Investment LLC first reported a position in Solid Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.